Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001535610-13-000036
Filing Date
2013-04-24
Accepted
2013-04-24 15:01:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 SABBY 13G SRPT 04.24.13 srpt0413.txt SC 13G 11815
  Complete submission text file 0001535610-13-000036.txt   13633
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 617-444-8424
Sarepta Therapeutics, Inc. (Subject) CIK: 0000873303 (see all company filings)

EIN.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-54847 | Film No.: 13779131
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458
Business Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458 646-307-4527
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G